Because of these issues, recent studies have investigated serum markers such as HE4 (6), TFPI2 (9), circulating tumor DNA (54, 55), DNA methylation (56), and circulating miRNA (11) as complementary markers to CA125. The gene discussed is WFDC2; the disease is neoplasm.